| Website | arcxis.com |
| Category | BioTech |
| Phone | 925-461-1300 |
| Employees |
| Series B, 10/07 Kaiser Permanente Ventures Alafi Capital Claremont Creek Ventures | $2M |
Arcxis Biotechnologies is focused on developing elegant, integrated and compact solutions to molecular diagnostic challenges. From proprietary microfluidics to advanced detection methods; streamlined sample preparation to comprehensive automation technology, we are in the business of making molecular methods more reliable, robust and accessible.
